Medicus Pharma (NASDAQ:MDCX) said on Friday it has submitted an application to the US Food and Drug Administration seeking ...
Physician and seasoned life sciences investor with more than two decades of experience across clinical practice, ...
First Olmsted syndrome patient dosed in global Phase 1b study Company now operating under its new name, Orvida Pharma NESS ZIONA, Israel, April 15, 2026 (GLOBE NEWSWIRE) -- Orvida Pharma (formerly ...
Poster #76954 highlights QTORIN™ rapamycin’s single phase anhydrous gel formulation designed to optimize dermal bioavailability of rapamycin for mTOR-driven skin diseases while overcoming the ...
Years of translational research have successfully improved treatment outcomes for common dermatological conditions such as ...
Paclitaxel remains first-line for cutaneous angiosarcoma, but absence of validated second-line therapy creates a major unmet ...
The ninth annual 'Plunge for Elodie' in Wellesley will raise funds and awareness for epidermolysis bullosa, a rare skin disease.
Researchers from Children's Hospital of Philadelphia (CHOP) developed a new RNA sequencing strategy that can reveal how ...
Muhammad Taluli arrived from Gaza at Jerusalem's Hadassah Medical Center a few months ago and unwrapped the cloth from his hands to reveal gray and white growths that looked like tree bark. The ...
There are certain risk factors that can make a person more prone to contracting the disease, some of which may be genetic.
The Grateful for Graham 5K raises money directly for the EB Research Partnership, the largest nonprofit leading EB research.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results